Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 11

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 24, Issue 11 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 11 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor

André Alves Moraes Gobbato, Tainah Babadópulos, Cintia Aparecida Rodrigues Santiago Gobbato, Jaime de Oliveira Ilha, Thiago Gagliano-Jucá & Gilberto De Nucci

Pages: 1399-1407

Published online: 30 Sep 2015

AbstractforA randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor | Full Text | References | PDF (503.3 KB)

268 Views
5 CrossRef citations
0Altmetric

Review

Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

Nisha Mohindra & Mark Agulnik (Associate Professor of Medicine) MD

Pages: 1409-1418

Published online: 08 Aug 2015

AbstractforTargeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas | Full Text | References | PDF (232.6 KB)

426 Views
4 CrossRef citations
0Altmetric

Potential breakthroughs with investigational drugs for hairy cell leukemia

Tadeusz Robak MD PhD, Anna Wolska MD PhD & Pawel Robak MD PhD

Pages: 1419-1431

Published online: 21 Aug 2015

AbstractforPotential breakthroughs with investigational drugs for hairy cell leukemia | Full Text | References | PDF (483.7 KB)

362 Views
9 CrossRef citations
0Altmetric

Experimental and investigational therapies for chemotherapy-induced anemia

Ugo Testa, Germana Castelli & Pelosi Elvira

Pages: 1433-1445

Published online: 10 Sep 2015

AbstractforExperimental and investigational therapies for chemotherapy-induced anemia | Full Text | References | PDF (243 KB)

431 Views
7 CrossRef citations
0Altmetric

Current Phase II drugs under investigation for the treatment of limb ischemia

Stavros Spiliopoulos MD PhD EBIR, Panagiotis Kitrou MD PhD, Konstantinos Katsanos MD MSc PhD EBIR & Dimitris Karnabatidis MD PhD EBIR

Pages: 1447-1458

Published online: 21 Aug 2015

AbstractforCurrent Phase II drugs under investigation for the treatment of limb ischemia | Full Text | References | PDF (313.2 KB)

284 Views
3 CrossRef citations
0Altmetric

Therapies in early development for the treatment of opiate addiction

Marta Rodríguez-Arias (Full Professor, Facultad de Psicología) PhD, María A Aguilar (Full Professor, Facultad de Psicología) PhD & José Miñarro (Full Professor, Facultad de Psicología) PhD

Pages: 1459-1472

Published online: 28 Sep 2015

AbstractforTherapies in early development for the treatment of opiate addiction | Full Text | References | PDF (256.5 KB)

616 Views
4 CrossRef citations
0Altmetric

Novel glucocorticoid receptor agonists in the treatment of asthma

Mario Cazzola (Chair of Respiratory Medicine) MD, Angelo Coppola (Chair of Respiratory Medicine) MD, Paola Rogliani (Chair of Respiratory Medicine) MD & Maria Gabriella Matera MD

Pages: 1473-1482

Published online: 19 Aug 2015

AbstractforNovel glucocorticoid receptor agonists in the treatment of asthma | Full Text | References | PDF (235.5 KB)

468 Views
15 CrossRef citations
0Altmetric

Discontinued Drug Perspectives

Discontinued dermatological drugs in 2014

Christina Phuong & Howard I Maibach

Pages: 1483-1491

Published online: 28 Sep 2015

AbstractforDiscontinued dermatological drugs in 2014 | Full Text | References | PDF (211.7 KB)

374 Views
2 CrossRef citations
0Altmetric

Drug Evaluation

Article

Entrectinib: a potent new TRK, ROS1, and ALK inhibitor

Christian Rolfo, Rossana Ruiz, Elisa Giovannetti, Ignacio Gil-Bazo, Antonio Russo, Francesco Passiglia, Marco Giallombardo, Marc Peeters & Luis Raez

Pages: 1493-1500

Published online: 12 Oct 2015

AbstractforEntrectinib: a potent new TRK, ROS1, and ALK inhibitor | Full Text | References | PDF (468.7 KB)

2408 Views
102 CrossRef citations
0Altmetric

Plazomicin: an investigational therapy for the treatment of urinary tract infections

Ilias Karaiskos, Maria Souli & Helen Giamarellou (Professor)

Pages: 1501-1511

Published online: 30 Sep 2015

AbstractforPlazomicin: an investigational therapy for the treatment of urinary tract infections | Full Text | References | PDF (388.9 KB)

884 Views
33 CrossRef citations
0Altmetric

Original Articles

Article

Page: 1513

Published online: 30 Oct 2015

18 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.11, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?